Medicare Negotiates 71% Discount on Novo's Ozempic, Wegovy
toomuchtodo Wednesday, November 26, 2025
Summary
The article discusses how Medicare successfully negotiated a 71% discount on the prices of Novo Nordisk's diabetes drugs Ozempic and Wegovy, a significant victory in the ongoing efforts to lower drug costs for the government healthcare program.
5
1
Summary
bloomberg.com